News
First Subject Dosed in CANbridge Pharma CAN106 rare disease trial in Singapore for PNH and complement dysregulation diseases Contacts CANbridge Pharmaceuticals Inc. [email protected] ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback